自体免疫疾病诊断市场－全球产业规模、份额、趋势、机会和预测，按组件、按测试类型、按疾病类型、按最终用户、按地区和竞争进行细分，2020 年至 2030 年

2024 年全球自体免疫疾病诊断市值为 57.4 亿美元，预计到 2030 年将达到 96.4 亿美元，预测期内的复合年增长率为 9.03%。全球自体免疫疾病诊断市场是指专注于自体免疫疾病诊断和检测的全球产业。自体免疫疾病是一组免疫系统错误地攻击身体自身的健康组织，导致各种健康问题的疾病。自体免疫疾病诊断市场涵盖旨在识别和监测这些疾病的各种产品、服务和技术。自体免疫疾病是一类超过 100 种慢性衰弱性疾病，影响约 3% 的美国人口，约 1,000 万人。一些最常见的自体免疫疾病包括肥胖、心血管疾病、第 2 型糖尿病和所有癌症。

关键市场驱动因素

自体免疫疾病盛行率上升

主要市场挑战

自体免疫疾病的复杂性

主要市场趋势

生物标记发现的进展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球自体免疫疾病诊断市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依组件（仪器、试剂、耗材）
  • 按测试类型（常规实验室测试、发炎标记、抗体和免疫学测试、其他）
  • 依疾病类型（系统性自体免疫疾病诊断、局部自体免疫疾病诊断）
  • 按最终使用者（医院和诊所、诊断中心、其他）
  • 按地区
  • 按公司分类（2024）
• 产品市场图
  • 按组件
  • 按测试类型
  • 依疾病类型
  • 按最终用户
  • 按地区

第六章：北美自体免疫疾病诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲自体免疫疾病诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙

第八章：亚太自体免疫疾病诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国

第九章：南美洲自体免疫疾病诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲自体免疫疾病诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：自体免疫疾病诊断市场：SWOT 分析

第 15 章：竞争格局

• Abbott Laboratories
• Siemens Healthineers AG
• Roche Diagnostics Corp
• Beckman Coulter Inc
• SQI Diagnostics Inc
• EUROIMMUN Medizinische Labordiagnostika AG
• Aesku Diagnostics GmbH & Co KG
• INOVA Diagnostics Inc
• Crescendo Bioscience LLC
• bioMerieux SA

第 16 章：策略建议

第17章调查会社について・免责事项

Global Autoimmune Disease Diagnostics Market was valued at USD 5.74 billion in 2024 and is expected to reach USD 9.64 billion by 2030 with a CAGR of 9.03% during the forecast period. The Global Autoimmune Disease Diagnostics Market refers to the worldwide industry focused on the diagnosis and testing of autoimmune diseases. Autoimmune diseases are a group of disorders in which the immune system mistakenly attacks the body's own healthy tissues, leading to various health problems. The market for autoimmune disease diagnostics encompasses a wide range of products, services, and technologies aimed at identifying and monitoring these conditions. Autoimmune diseases are a group of more than 100 chronic, debilitating conditions that affect approximately 3% of the US population, or about 10 million people. Some of the most common autoimmune diseases include obesity, cardiovascular diseases, type 2 diabetes mellitus, and all cancers.

Key Market Drivers

Rising Prevalence of Autoimmune Diseases

Autoimmune diseases have become a growing global health concern, affecting millions of people worldwide. These conditions occur when the body's immune system mistakenly targets its own tissues, leading to chronic inflammation and a wide range of health issues. As the prevalence of autoimmune diseases continues to rise, the Global Autoimmune Disease Diagnostics Market is experiencing significant growth. Autoimmune diseases are no longer considered rare. They have reached epidemic proportions, with millions of people across the globe suffering from various autoimmune conditions. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, Crohn's disease, and type 1 diabetes. The sheer volume of patients seeking diagnosis and treatment has boosted the demand for autoimmune disease diagnostics. Early diagnosis is crucial for managing autoimmune diseases effectively. Many of these conditions exhibit subtle symptoms in their early stages, making accurate and timely diagnosis challenging. However, as awareness about autoimmune diseases increases, individuals are more likely to seek medical attention when experiencing symptoms, driving the need for diagnostic tests that can confirm or rule out these conditions.

Moreover, the rising prevalence of autoimmune diseases has coincided with significant technological advancements in healthcare. Diagnostic tools and techniques have evolved rapidly, providing healthcare professionals with more accurate and efficient ways to detect autoimmune diseases. These advancements include serology tests, genetic testing, imaging modalities, and biomarker-based assays. Such innovations enhance the diagnostic capabilities and contribute to early intervention. The growth of the autoimmune disease diagnostics market is also linked to the trend of personalized medicine. Tailoring treatments based on an individual's unique genetic and immunological profile is gaining prominence. To prescribe personalized therapies effectively, precise diagnostics are required to identify the specific autoimmune disease and its severity, enabling clinicians to choose the most suitable treatment options. For instance, a study published in the American Journal of Managed Care (AJMC) in May 2021 reported an estimated prevalence of 276 cases per million adults for scleroderma in the U.S. A recent study found that autoimmune disorders now affect about one in ten individuals, with 80-100 known autoimmune diseases affecting more than 14 million Americans.

Key Market Challenges

Complexity of Autoimmune Diseases

One of the fundamental challenges in autoimmune disease diagnostics is the sheer complexity of these conditions. Autoimmune diseases can present with a wide array of symptoms, and their underlying mechanisms are often intricate and multifaceted. This complexity makes it challenging to develop diagnostic tests that are both accurate and comprehensive.

Key Market Trends

Advances in Biomarker Discovery

Biomarkers play a crucial role in autoimmune disease diagnostics. Ongoing research is leading to the discovery of novel biomarkers that can improve diagnostic accuracy. These biomarkers are expected to become integral in identifying autoimmune diseases at earlier stages and monitoring disease progression more effectively.

Key Market Players

• Abbott Laboratories
• Siemens Healthineers AG
• Roche Diagnostics Corp
• Beckman Coulter Inc
• SQI Diagnostics Inc
• EUROIMMUN Medizinische Labordiagnostika AG
• Aesku Diagnostics GmbH & Co KG
• INOVA Diagnostics Inc
• Crescendo Bioscience LLC
• bioMerieux SA

Report Scope:

In this report, the Global Autoimmune Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Autoimmune Disease Diagnostics Market, By Component:

• Instruments
• Reagents
• Consumables

Autoimmune Disease Diagnostics Market, By Test Type:

• Routine Laboratory Tests
• Inflammatory Markers
• Antibodies & Immunologic Tests
• Others

Autoimmune Disease Diagnostics Market, By Disease Type:

• Systemic Autoimmune Disease Diagnostics
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus
  • Others
• Localized Autoimmune Disease Diagnostics
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Hashimoto's Thyroiditis
  • Others

Autoimmune Disease Diagnostics Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers
• Others

Autoimmune Disease Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Autoimmune Disease Diagnostics Market.

Available Customizations:

Global Autoimmune Disease Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Autoimmune Disease Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Instruments, Reagents, Consumables)
  • 5.2.2. By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others)
  • 5.2.3. By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics)
    • 5.2.3.1. By Systemic Autoimmune Diseases (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others)
    • 5.2.3.2. By Localized Autoimmune Diseases (Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Diagnostic Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Component
  • 5.3.2. By Test Type
  • 5.3.3. By Disease Type
  • 5.3.4. By End User
  • 5.3.5. By Region

6. North America Autoimmune Disease Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component (Instruments, Reagents, Consumables)
  • 6.2.2. By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others)
  • 6.2.3. By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics)
  • 6.2.4. By End User (Hospitals & Clinics, Diagnostic Centers, Others)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Autoimmune Disease Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Disease Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Autoimmune Disease Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Disease Type>
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Autoimmune Disease Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Disease Type
      • 6.3.3.2.4. By End User

7. Europe Autoimmune Disease Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component (Instruments, Reagents, Consumables)
  • 7.2.2. By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others)
  • 7.2.3. By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics)
  • 7.2.4. By End User (Hospitals & Clinics, Diagnostic Centers, Others)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Autoimmune Disease Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Disease Type
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Autoimmune Disease Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Disease Type
      • 7.3.2.2.4. By End User
  • 7.3.3. France Autoimmune Disease Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Disease Type
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Autoimmune Disease Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Disease Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Autoimmune Disease Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Disease Type
      • 7.3.5.2.4. By End User

8. Asia-Pacific Autoimmune Disease Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component (Instruments, Reagents, Consumables)
  • 8.2.2. By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others)
  • 8.2.3. By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics)
  • 8.2.4. By End User (Hospitals & Clinics, Diagnostic Centers, Others)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Autoimmune Disease Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Disease Type
      • 8.3.1.2.4. By End User
  • 8.3.2. Japan Autoimmune Disease Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Disease Type
      • 8.3.2.2.4. By End User
  • 8.3.3. India Autoimmune Disease Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Disease Type
      • 8.3.3.2.4. By End User
  • 8.3.4. Australia Autoimmune Disease Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
  • 8.3.5. South Korea Autoimmune Disease Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By Disease Type
      • 8.3.5.2.4. By End User

9. South America Autoimmune Disease Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component (Instruments, Reagents, Consumables)
  • 9.2.2. By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others)
  • 9.2.3. By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics)
  • 9.2.4. By End User (Hospitals & Clinics, Diagnostic Centers, Others)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Autoimmune Disease Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Disease Type
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Autoimmune Disease Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Disease Type
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Autoimmune Disease Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Disease Type
      • 9.3.3.2.4. By End User

10. Middle East and Africa Autoimmune Disease Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component (Instruments, Reagents, Consumables)
  • 10.2.2. By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others)
  • 10.2.3. By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics)>
  • 10.2.4. By End User (Hospitals & Clinics, Diagnostic Centers, Others)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Autoimmune Disease Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Disease Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Autoimmune Disease Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Disease Type
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Autoimmune Disease Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Disease Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Autoimmune Disease Diagnostics Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Siemens Healthineers AG
• 15.3. Roche Diagnostics Corp
• 15.4. Beckman Coulter Inc
• 15.5. SQI Diagnostics Inc
• 15.6. EUROIMMUN Medizinische Labordiagnostika AG
• 15.7. Aesku Diagnostics GmbH & Co KG
• 15.8. INOVA Diagnostics Inc
• 15.9. Crescendo Bioscience LLC
• 15.10. bioMerieux SA

16. Strategic Recommendations

17. About Us & Disclaimer